

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.87533200 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.68369033 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.39802093 |
| 4 | retinal cone cell development (GO:0046549) | 5.33110878 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.30777499 |
| 6 | vocalization behavior (GO:0071625) | 5.23661378 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.22798970 |
| 8 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.14493854 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.96004046 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.92383166 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.87508457 |
| 12 | protein localization to synapse (GO:0035418) | 4.83888030 |
| 13 | regulation of acrosome reaction (GO:0060046) | 4.77161782 |
| 14 | glutamate secretion (GO:0014047) | 4.77123139 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.73769795 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.67139031 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.64542749 |
| 18 | regulation of female gonad development (GO:2000194) | 4.53448389 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.52259213 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.38514810 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.17800224 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.17791485 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.17592111 |
| 24 | glutamate receptor signaling pathway (GO:0007215) | 4.16305262 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.10657083 |
| 26 | neuronal action potential propagation (GO:0019227) | 4.09452574 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.08781511 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.06870703 |
| 29 | regulation of DNA methylation (GO:0044030) | 4.03086192 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.00073548 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.95910941 |
| 32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.94099177 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.92924564 |
| 34 | regulation of meiosis I (GO:0060631) | 3.89557237 |
| 35 | exploration behavior (GO:0035640) | 3.88449491 |
| 36 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.87781406 |
| 37 | piRNA metabolic process (GO:0034587) | 3.86008312 |
| 38 | cellular potassium ion homeostasis (GO:0030007) | 3.82959099 |
| 39 | long-term memory (GO:0007616) | 3.80377117 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.78900491 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.78832516 |
| 42 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.78231466 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.77899373 |
| 44 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.77853827 |
| 45 | long-term synaptic potentiation (GO:0060291) | 3.77073597 |
| 46 | response to histamine (GO:0034776) | 3.76226756 |
| 47 | positive regulation of neurotransmitter transport (GO:0051590) | 3.75785953 |
| 48 | meiotic cell cycle (GO:0051321) | 3.74840906 |
| 49 | presynaptic membrane assembly (GO:0097105) | 3.69138348 |
| 50 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.69104916 |
| 51 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.67165948 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 3.64213036 |
| 53 | positive regulation of meiosis (GO:0045836) | 3.64092002 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.62895994 |
| 55 | amino acid import (GO:0043090) | 3.60538796 |
| 56 | potassium ion import (GO:0010107) | 3.53698910 |
| 57 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.52177612 |
| 58 | regulation of female receptivity (GO:0045924) | 3.48574819 |
| 59 | thyroid hormone generation (GO:0006590) | 3.48246536 |
| 60 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.47904648 |
| 61 | thyroid hormone metabolic process (GO:0042403) | 3.47032509 |
| 62 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.46856671 |
| 63 | glycine transport (GO:0015816) | 3.45233364 |
| 64 | postsynaptic membrane organization (GO:0001941) | 3.45041461 |
| 65 | presynaptic membrane organization (GO:0097090) | 3.42488195 |
| 66 | multicellular organism reproduction (GO:0032504) | 3.41006854 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.39350826 |
| 68 | dendritic spine morphogenesis (GO:0060997) | 3.37690617 |
| 69 | neurotransmitter transport (GO:0006836) | 3.37344402 |
| 70 | positive regulation of meiotic cell cycle (GO:0051446) | 3.37192378 |
| 71 | transmission of nerve impulse (GO:0019226) | 3.36792982 |
| 72 | relaxation of smooth muscle (GO:0044557) | 3.35762457 |
| 73 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.34289392 |
| 74 | auditory behavior (GO:0031223) | 3.32314918 |
| 75 | response to auditory stimulus (GO:0010996) | 3.31781552 |
| 76 | regulation of neurotransmitter secretion (GO:0046928) | 3.31171903 |
| 77 | oocyte development (GO:0048599) | 3.29783941 |
| 78 | neuron recognition (GO:0008038) | 3.29460501 |
| 79 | behavioral defense response (GO:0002209) | 3.29206594 |
| 80 | behavioral fear response (GO:0001662) | 3.29206594 |
| 81 | female mating behavior (GO:0060180) | 3.26101520 |
| 82 | cochlea development (GO:0090102) | 3.24405614 |
| 83 | positive regulation of synaptic transmission (GO:0050806) | 3.23714255 |
| 84 | regulation of glutamate secretion (GO:0014048) | 3.23003648 |
| 85 | membrane hyperpolarization (GO:0060081) | 3.22083030 |
| 86 | DNA methylation involved in gamete generation (GO:0043046) | 3.20072291 |
| 87 | layer formation in cerebral cortex (GO:0021819) | 3.19747599 |
| 88 | proline transport (GO:0015824) | 3.19294464 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 3.17759508 |
| 90 | regulation of steroid hormone secretion (GO:2000831) | 3.14194363 |
| 91 | striatum development (GO:0021756) | 3.14110171 |
| 92 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13896413 |
| 93 | membrane depolarization (GO:0051899) | 3.13266607 |
| 94 | behavioral response to cocaine (GO:0048148) | 3.12865707 |
| 95 | righting reflex (GO:0060013) | 3.10832133 |
| 96 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.10734468 |
| 97 | L-amino acid import (GO:0043092) | 3.10504102 |
| 98 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.10412813 |
| 99 | activation of protein kinase A activity (GO:0034199) | 3.09766595 |
| 100 | regulation of neurotransmitter transport (GO:0051588) | 3.09752836 |
| 101 | regulation of neurotransmitter levels (GO:0001505) | 3.06546060 |
| 102 | fear response (GO:0042596) | 3.06208739 |
| 103 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05636193 |
| 104 | startle response (GO:0001964) | 3.05031679 |
| 105 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04873263 |
| 106 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04743992 |
| 107 | learning (GO:0007612) | 3.04471773 |
| 108 | regulation of vesicle fusion (GO:0031338) | 3.04380364 |
| 109 | synaptic vesicle endocytosis (GO:0048488) | 3.03789391 |
| 110 | cellular sodium ion homeostasis (GO:0006883) | 3.03222854 |
| 111 | sodium ion export (GO:0071436) | 3.02987757 |
| 112 | prepulse inhibition (GO:0060134) | 3.02632002 |
| 113 | regulation of dendritic spine development (GO:0060998) | 3.01663901 |
| 114 | synaptic transmission, dopaminergic (GO:0001963) | 3.00639781 |
| 115 | regulation of synaptic transmission (GO:0050804) | 3.00572999 |
| 116 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.99467730 |
| 117 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.99361255 |
| 118 | calcium ion-dependent exocytosis (GO:0017156) | 2.97060709 |
| 119 | negative regulation of amino acid transport (GO:0051956) | 2.94306864 |
| 120 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93565376 |
| 121 | synaptic transmission (GO:0007268) | 2.92782367 |
| 122 | membrane depolarization during action potential (GO:0086010) | 2.91980044 |
| 123 | dopamine biosynthetic process (GO:0042416) | 2.91105563 |
| 124 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90858185 |
| 125 | mechanosensory behavior (GO:0007638) | 2.90812138 |
| 126 | female gamete generation (GO:0007292) | 2.90475151 |
| 127 | chemosensory behavior (GO:0007635) | 2.87326736 |
| 128 | long term synaptic depression (GO:0060292) | 2.85583514 |
| 129 | visual learning (GO:0008542) | 2.84891393 |
| 130 | regulation of meiosis (GO:0040020) | 2.83544771 |
| 131 | potassium ion homeostasis (GO:0055075) | 2.79033713 |
| 132 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.77783701 |
| 133 | negative regulation of reproductive process (GO:2000242) | 2.72780328 |
| 134 | relaxation of cardiac muscle (GO:0055119) | 2.70740487 |
| 135 | regulation of cell maturation (GO:1903429) | 2.70265362 |
| 136 | detection of calcium ion (GO:0005513) | 2.69350060 |
| 137 | cAMP-mediated signaling (GO:0019933) | 2.61817615 |
| 138 | type B pancreatic cell development (GO:0003323) | 2.55094363 |
| 139 | potassium ion transmembrane transport (GO:0071805) | 2.52911246 |
| 140 | cellular potassium ion transport (GO:0071804) | 2.52911246 |
| 141 | axon ensheathment in central nervous system (GO:0032291) | 2.51933941 |
| 142 | central nervous system myelination (GO:0022010) | 2.51933941 |
| 143 | insulin secretion (GO:0030073) | 2.46123401 |
| 144 | * phosphorelay signal transduction system (GO:0000160) | 2.42361140 |
| 145 | regulation of exocytosis (GO:0017157) | 2.40638536 |
| 146 | adult walking behavior (GO:0007628) | 2.40038094 |
| 147 | aggressive behavior (GO:0002118) | 2.39900856 |
| 148 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.39202533 |
| 149 | sleep (GO:0030431) | 2.38049231 |
| 150 | positive regulation of dendritic spine development (GO:0060999) | 2.37509169 |
| 151 | potassium ion transport (GO:0006813) | 2.37289261 |
| 152 | cerebellar granule cell differentiation (GO:0021707) | 2.36496357 |
| 153 | regulation of meiotic cell cycle (GO:0051445) | 2.36380075 |
| 154 | serotonin metabolic process (GO:0042428) | 2.35206730 |
| 155 | phospholipid dephosphorylation (GO:0046839) | 2.34770259 |
| 156 | positive regulation of exocytosis (GO:0045921) | 2.33790874 |
| 157 | positive regulation of gastrulation (GO:2000543) | 2.31854759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28592532 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.94547394 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11174691 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06562575 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.98628053 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91304631 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.66599311 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64129363 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61373428 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61373428 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57337006 |
| 12 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.53734800 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52001929 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49384294 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47405345 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46134876 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43228510 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43126294 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40372894 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34223902 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13578626 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.10570076 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10108651 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10032783 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.94890264 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94735750 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92965667 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85834465 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81638672 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79210460 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78173668 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77196761 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76956064 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.68827749 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64530883 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63716011 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60450453 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55281092 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.54403667 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54361762 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52068186 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50784129 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44201527 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43896557 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41982494 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.41315483 |
| 47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38098915 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37530729 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35730615 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35651501 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34045928 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32046306 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31425021 |
| 54 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.31299256 |
| 55 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30754345 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30540012 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28173992 |
| 58 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.27904340 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27026260 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26887320 |
| 61 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23762266 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23402130 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23054549 |
| 64 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22882193 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22663437 |
| 66 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22544904 |
| 67 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22465985 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21839049 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20926571 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20926571 |
| 71 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19902746 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.18606559 |
| 73 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16747302 |
| 74 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16677100 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15294841 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14756093 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14743502 |
| 78 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.14490279 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13882900 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13882900 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13382104 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12513829 |
| 83 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09447047 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09131706 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08097713 |
| 86 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07836997 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07116914 |
| 88 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06998795 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06341079 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06026939 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05529058 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04833625 |
| 93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04063943 |
| 94 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03075940 |
| 95 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02593299 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02111630 |
| 97 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01727506 |
| 98 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00357953 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99263609 |
| 100 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98967279 |
| 101 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98192983 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97439543 |
| 103 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97105522 |
| 104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96936399 |
| 105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96871119 |
| 106 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96870553 |
| 107 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95583726 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95516725 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93945498 |
| 110 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93817866 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93220421 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93100153 |
| 113 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93036417 |
| 114 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.92668737 |
| 115 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.92576820 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92525850 |
| 117 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92437673 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.92363871 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91975888 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91369735 |
| 121 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90846229 |
| 122 | EWS_26573619_Chip-Seq_HEK293_Human | 0.90738398 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.13564454 |
| 2 | MP0003880_abnormal_central_pattern | 5.70508776 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.05005753 |
| 4 | MP0002822_catalepsy | 3.61698178 |
| 5 | MP0009745_abnormal_behavioral_response | 3.56245292 |
| 6 | MP0004270_analgesia | 3.34918363 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.30537668 |
| 8 | MP0002064_seizures | 3.21345258 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.10257506 |
| 10 | MP0009046_muscle_twitch | 3.00400965 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.89214548 |
| 12 | MP0003718_maternal_effect | 2.86899931 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.85410013 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.82338306 |
| 15 | MP0001486_abnormal_startle_reflex | 2.67809024 |
| 16 | MP0002272_abnormal_nervous_system | 2.61573459 |
| 17 | MP0002736_abnormal_nociception_after | 2.42608995 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.36104648 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.35555917 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.33696351 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 2.23238677 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.11402740 |
| 23 | MP0005646_abnormal_pituitary_gland | 2.02282313 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.98410984 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.89881772 |
| 26 | MP0001970_abnormal_pain_threshold | 1.78666004 |
| 27 | MP0003879_abnormal_hair_cell | 1.73755478 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.72267185 |
| 29 | MP0001984_abnormal_olfaction | 1.72097407 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.69697646 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.66792610 |
| 32 | MP0008569_lethality_at_weaning | 1.65842430 |
| 33 | MP0004924_abnormal_behavior | 1.61774815 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.61774815 |
| 35 | MP0003890_abnormal_embryonic-extraembry | 1.58561725 |
| 36 | MP0003329_amyloid_beta_deposits | 1.55607526 |
| 37 | MP0003787_abnormal_imprinting | 1.55315035 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.53900614 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.50981919 |
| 40 | MP0000778_abnormal_nervous_system | 1.47185233 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.46119324 |
| 42 | MP0001529_abnormal_vocalization | 1.43281629 |
| 43 | MP0002184_abnormal_innervation | 1.43050708 |
| 44 | MP0003633_abnormal_nervous_system | 1.39436928 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.37996099 |
| 46 | MP0005395_other_phenotype | 1.36298545 |
| 47 | MP0001188_hyperpigmentation | 1.35817202 |
| 48 | MP0006292_abnormal_olfactory_placode | 1.30980312 |
| 49 | MP0004858_abnormal_nervous_system | 1.30960411 |
| 50 | MP0002066_abnormal_motor_capabilities/c | 1.28241475 |
| 51 | MP0004885_abnormal_endolymph | 1.28203979 |
| 52 | MP0008789_abnormal_olfactory_epithelium | 1.28065181 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.28038337 |
| 54 | MP0000955_abnormal_spinal_cord | 1.26290878 |
| 55 | MP0002234_abnormal_pharynx_morphology | 1.21271029 |
| 56 | MP0002090_abnormal_vision | 1.19688992 |
| 57 | MP0003121_genomic_imprinting | 1.18309215 |
| 58 | MP0001944_abnormal_pancreas_morphology | 1.16772509 |
| 59 | MP0005253_abnormal_eye_physiology | 1.16760100 |
| 60 | MP0004142_abnormal_muscle_tone | 1.16346489 |
| 61 | MP0003136_yellow_coat_color | 1.16191783 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.14679754 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.13219108 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.12815665 |
| 65 | MP0002229_neurodegeneration | 1.12487173 |
| 66 | MP0000566_synostosis | 1.12281933 |
| 67 | MP0003631_nervous_system_phenotype | 1.10916146 |
| 68 | MP0000681_abnormal_thyroid_gland | 1.10391500 |
| 69 | MP0010678_abnormal_skin_adnexa | 1.08968020 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.07545927 |
| 71 | MP0001905_abnormal_dopamine_level | 1.04352605 |
| 72 | MP0008057_abnormal_DNA_replication | 1.03404141 |
| 73 | MP0003122_maternal_imprinting | 1.00443260 |
| 74 | MP0001929_abnormal_gametogenesis | 1.00253703 |
| 75 | MP0001177_atelectasis | 0.98767699 |
| 76 | MP0003699_abnormal_female_reproductive | 0.97199781 |
| 77 | MP0000751_myopathy | 0.96473447 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.95260315 |
| 79 | MP0000427_abnormal_hair_cycle | 0.95144959 |
| 80 | MP0003075_altered_response_to | 0.95119024 |
| 81 | MP0004085_abnormal_heartbeat | 0.94518571 |
| 82 | MP0003690_abnormal_glial_cell | 0.94204092 |
| 83 | MP0004742_abnormal_vestibular_system | 0.93356989 |
| 84 | MP0002152_abnormal_brain_morphology | 0.92699581 |
| 85 | MP0008872_abnormal_physiological_respon | 0.92674417 |
| 86 | MP0002160_abnormal_reproductive_system | 0.90579103 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.89796262 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.89485919 |
| 89 | MP0004215_abnormal_myocardial_fiber | 0.89151523 |
| 90 | MP0008874_decreased_physiological_sensi | 0.89133553 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 0.88740189 |
| 92 | MP0002210_abnormal_sex_determination | 0.88387983 |
| 93 | MP0000026_abnormal_inner_ear | 0.85803345 |
| 94 | MP0001963_abnormal_hearing_physiology | 0.84613311 |
| 95 | MP0002161_abnormal_fertility/fecundity | 0.83736802 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.83545299 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.83332737 |
| 98 | MP0003195_calcinosis | 0.82017071 |
| 99 | MP0004484_altered_response_of | 0.81832275 |
| 100 | MP0005171_absent_coat_pigmentation | 0.79714104 |
| 101 | MP0005623_abnormal_meninges_morphology | 0.79681063 |
| 102 | MP0002928_abnormal_bile_duct | 0.79576738 |
| 103 | MP0003634_abnormal_glial_cell | 0.79561670 |
| 104 | MP0005410_abnormal_fertilization | 0.78989630 |
| 105 | MP0003698_abnormal_male_reproductive | 0.78585529 |
| 106 | MP0000383_abnormal_hair_follicle | 0.78317583 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.78175577 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 0.75733243 |
| 109 | MP0001664_abnormal_digestion | 0.74969141 |
| 110 | MP0000653_abnormal_sex_gland | 0.74903191 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.73462757 |
| 112 | MP0003953_abnormal_hormone_level | 0.72782110 |
| 113 | MP0005409_darkened_coat_color | 0.72771864 |
| 114 | MP0005535_abnormal_body_temperature | 0.72147111 |
| 115 | MP0005195_abnormal_posterior_eye | 0.70889944 |
| 116 | MP0000569_abnormal_digit_pigmentation | 0.66600056 |
| 117 | MP0003632_abnormal_nervous_system | 0.65958626 |
| 118 | MP0000920_abnormal_myelination | 0.63746936 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.63663507 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.63501000 |
| 121 | MP0000604_amyloidosis | 0.62422013 |
| 122 | MP0005499_abnormal_olfactory_system | 0.60163695 |
| 123 | MP0005394_taste/olfaction_phenotype | 0.60163695 |
| 124 | MP0008961_abnormal_basal_metabolism | 0.58818613 |
| 125 | MP0005595_abnormal_vascular_smooth | 0.57327883 |
| 126 | MP0004233_abnormal_muscle_weight | 0.57059871 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.56158094 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.55648522 |
| 129 | MP0004043_abnormal_pH_regulation | 0.54751436 |
| 130 | MP0001943_abnormal_respiration | 0.54542931 |
| 131 | MP0003283_abnormal_digestive_organ | 0.54489837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.65669506 |
| 2 | Myokymia (HP:0002411) | 6.33750853 |
| 3 | Focal seizures (HP:0007359) | 5.87414168 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.68865329 |
| 5 | Atonic seizures (HP:0010819) | 5.09127284 |
| 6 | Febrile seizures (HP:0002373) | 4.86111567 |
| 7 | Absence seizures (HP:0002121) | 4.51772841 |
| 8 | Visual hallucinations (HP:0002367) | 4.48780470 |
| 9 | Dialeptic seizures (HP:0011146) | 4.22879078 |
| 10 | Increased circulating renin level (HP:0000848) | 4.12700490 |
| 11 | Hyperventilation (HP:0002883) | 4.12548807 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.09369960 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.94593178 |
| 14 | Congenital sensorineural hearing impairment (HP:0008527) | 3.77313820 |
| 15 | Broad-based gait (HP:0002136) | 3.66464783 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.56995473 |
| 17 | Limb dystonia (HP:0002451) | 3.45922214 |
| 18 | Thyroid-stimulating hormone excess (HP:0002925) | 3.34213612 |
| 19 | Action tremor (HP:0002345) | 3.33504522 |
| 20 | Goiter (HP:0000853) | 3.31092780 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.27168789 |
| 22 | Poor eye contact (HP:0000817) | 3.19155093 |
| 23 | Truncal ataxia (HP:0002078) | 3.05991785 |
| 24 | Amblyopia (HP:0000646) | 3.03302028 |
| 25 | Supranuclear gaze palsy (HP:0000605) | 3.02620203 |
| 26 | Depression (HP:0000716) | 3.02226881 |
| 27 | Oligodactyly (hands) (HP:0001180) | 2.98367430 |
| 28 | Anxiety (HP:0000739) | 2.98015178 |
| 29 | Abnormality of abdominal situs (HP:0011620) | 2.97256793 |
| 30 | Abdominal situs inversus (HP:0003363) | 2.97256793 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.95074688 |
| 32 | * Dysdiadochokinesis (HP:0002075) | 2.91564437 |
| 33 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.91236749 |
| 34 | Dysmetria (HP:0001310) | 2.89483898 |
| 35 | Central scotoma (HP:0000603) | 2.88926511 |
| 36 | Abnormal social behavior (HP:0012433) | 2.88877633 |
| 37 | Impaired social interactions (HP:0000735) | 2.88877633 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.86816826 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.80652221 |
| 40 | Postural instability (HP:0002172) | 2.79720615 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.79227512 |
| 42 | Hemiparesis (HP:0001269) | 2.73993462 |
| 43 | Hypoglycemic seizures (HP:0002173) | 2.71628070 |
| 44 | Ankle clonus (HP:0011448) | 2.68955872 |
| 45 | Genetic anticipation (HP:0003743) | 2.67922119 |
| 46 | Dysmetric saccades (HP:0000641) | 2.65594741 |
| 47 | Impaired smooth pursuit (HP:0007772) | 2.64908489 |
| 48 | Scanning speech (HP:0002168) | 2.64508220 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.62066696 |
| 50 | Anterior segment dysgenesis (HP:0007700) | 2.57795969 |
| 51 | Abnormality of macular pigmentation (HP:0008002) | 2.56664931 |
| 52 | Supernumerary spleens (HP:0009799) | 2.55776134 |
| 53 | Papillary thyroid carcinoma (HP:0002895) | 2.55499889 |
| 54 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.54475878 |
| 55 | Hypoplasia of the fovea (HP:0007750) | 2.54475878 |
| 56 | Stereotypic behavior (HP:0000733) | 2.53706868 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.51900757 |
| 58 | Abnormality of binocular vision (HP:0011514) | 2.50932406 |
| 59 | Diplopia (HP:0000651) | 2.50932406 |
| 60 | Drooling (HP:0002307) | 2.50770837 |
| 61 | Excessive salivation (HP:0003781) | 2.50770837 |
| 62 | Status epilepticus (HP:0002133) | 2.50261413 |
| 63 | Thyroid carcinoma (HP:0002890) | 2.49735652 |
| 64 | Decreased circulating renin level (HP:0003351) | 2.47210881 |
| 65 | Hemiplegia (HP:0002301) | 2.46662321 |
| 66 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.45963927 |
| 67 | Abnormal ciliary motility (HP:0012262) | 2.43363856 |
| 68 | Dyschromatopsia (HP:0007641) | 2.40438062 |
| 69 | Absent speech (HP:0001344) | 2.40139482 |
| 70 | Torticollis (HP:0000473) | 2.39483612 |
| 71 | Rhinitis (HP:0012384) | 2.38607262 |
| 72 | Gait imbalance (HP:0002141) | 2.36448321 |
| 73 | Apathy (HP:0000741) | 2.35563424 |
| 74 | Scotoma (HP:0000575) | 2.34654379 |
| 75 | Large for gestational age (HP:0001520) | 2.32528352 |
| 76 | Enlarged penis (HP:0000040) | 2.31724581 |
| 77 | Infertility (HP:0000789) | 2.30979180 |
| 78 | Bundle branch block (HP:0011710) | 2.30659792 |
| 79 | Impaired vibratory sensation (HP:0002495) | 2.29660001 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.28745098 |
| 81 | Hyperthyroidism (HP:0000836) | 2.27921080 |
| 82 | Hypothermia (HP:0002045) | 2.26771882 |
| 83 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.26602448 |
| 84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26548225 |
| 85 | Abnormality of the lower motor neuron (HP:0002366) | 2.23597848 |
| 86 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.22798388 |
| 87 | Mutism (HP:0002300) | 2.20074141 |
| 88 | Congenital primary aphakia (HP:0007707) | 2.17194009 |
| 89 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.16944635 |
| 90 | Choroideremia (HP:0001139) | 2.16703952 |
| 91 | Focal dystonia (HP:0004373) | 2.16291139 |
| 92 | Megalencephaly (HP:0001355) | 2.16265405 |
| 93 | Generalized myoclonic seizures (HP:0002123) | 2.15932693 |
| 94 | Progressive inability to walk (HP:0002505) | 2.14379624 |
| 95 | Aplasia involving bones of the extremities (HP:0009825) | 2.13602205 |
| 96 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.13602205 |
| 97 | Aplasia of the phalanges of the hand (HP:0009802) | 2.13602205 |
| 98 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.13526795 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.13441483 |
| 100 | Urethral obstruction (HP:0000796) | 2.12825176 |
| 101 | Abnormality of renin-angiotensin system (HP:0000847) | 2.11857152 |
| 102 | Urinary urgency (HP:0000012) | 2.11359115 |
| 103 | Diminished motivation (HP:0000745) | 2.10738094 |
| 104 | Abnormality of the fovea (HP:0000493) | 2.09514627 |
| 105 | Median cleft lip (HP:0000161) | 2.08886205 |
| 106 | Resting tremor (HP:0002322) | 2.08658137 |
| 107 | * Bradykinesia (HP:0002067) | 2.06823614 |
| 108 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.06774190 |
| 109 | Annular pancreas (HP:0001734) | 2.06171865 |
| 110 | Intention tremor (HP:0002080) | 2.05224030 |
| 111 | Hyperactive renin-angiotensin system (HP:0000841) | 2.04751698 |
| 112 | Inability to walk (HP:0002540) | 2.03814283 |
| 113 | Spastic gait (HP:0002064) | 2.03299694 |
| 114 | Molar tooth sign on MRI (HP:0002419) | 2.03279819 |
| 115 | Abnormality of midbrain morphology (HP:0002418) | 2.03279819 |
| 116 | Hyperglycemia (HP:0003074) | 2.01929156 |
| 117 | Hypsarrhythmia (HP:0002521) | 2.01898397 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01679655 |
| 119 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.00983861 |
| 120 | Abnormality of the labia minora (HP:0012880) | 1.99567360 |
| 121 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.99054592 |
| 122 | Absent/shortened dynein arms (HP:0200106) | 1.99054592 |
| 123 | Decreased central vision (HP:0007663) | 1.97854114 |
| 124 | Abnormal drinking behavior (HP:0030082) | 1.97675981 |
| 125 | Polydipsia (HP:0001959) | 1.97675981 |
| 126 | Protruding tongue (HP:0010808) | 1.96519625 |
| 127 | Blue irides (HP:0000635) | 1.96076657 |
| 128 | Medial flaring of the eyebrow (HP:0010747) | 1.95417379 |
| 129 | Craniofacial dystonia (HP:0012179) | 1.95089689 |
| 130 | Fair hair (HP:0002286) | 1.94960940 |
| 131 | Osteomalacia (HP:0002749) | 1.94157481 |
| 132 | Fetal akinesia sequence (HP:0001989) | 1.93291168 |
| 133 | Incomplete penetrance (HP:0003829) | 1.93160088 |
| 134 | Lower limb muscle weakness (HP:0007340) | 1.92376726 |
| 135 | Papilledema (HP:0001085) | 1.90770871 |
| 136 | Gait ataxia (HP:0002066) | 1.88590719 |
| 137 | Polyphagia (HP:0002591) | 1.88583226 |
| 138 | Hypoventilation (HP:0002791) | 1.88479572 |
| 139 | Lower limb amyotrophy (HP:0007210) | 1.88378173 |
| 140 | Abnormal EKG (HP:0003115) | 1.86191329 |
| 141 | Impulsivity (HP:0100710) | 1.86120038 |
| 142 | Hyperaldosteronism (HP:0000859) | 1.85387257 |
| 143 | Ketoacidosis (HP:0001993) | 1.84728625 |
| 144 | Specific learning disability (HP:0001328) | 1.83475212 |
| 145 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.83074755 |
| 146 | Male infertility (HP:0003251) | 1.82614295 |
| 147 | Abnormality of saccadic eye movements (HP:0000570) | 1.82589686 |
| 148 | Clumsiness (HP:0002312) | 1.82002005 |
| 149 | Ventricular fibrillation (HP:0001663) | 1.79835733 |
| 150 | Prolonged QT interval (HP:0001657) | 1.79704249 |
| 151 | Thickened helices (HP:0000391) | 1.78187727 |
| 152 | Pheochromocytoma (HP:0002666) | 1.77075781 |
| 153 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.77055646 |
| 154 | Septo-optic dysplasia (HP:0100842) | 1.75961578 |
| 155 | Facial hemangioma (HP:0000329) | 1.75188494 |
| 156 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.74533794 |
| 157 | Short tibia (HP:0005736) | 1.71854164 |
| 158 | Postural tremor (HP:0002174) | 1.70277378 |
| 159 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.69256789 |
| 160 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.69256789 |
| 161 | Lip pit (HP:0100267) | 1.68059829 |
| 162 | Oligodactyly (HP:0012165) | 1.67549687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.90473223 |
| 2 | NTRK3 | 4.47606663 |
| 3 | CASK | 3.14371027 |
| 4 | DAPK2 | 2.85540592 |
| 5 | MAP3K4 | 2.80817941 |
| 6 | MAP3K9 | 2.78373125 |
| 7 | MAP2K7 | 2.51939751 |
| 8 | FRK | 2.51887818 |
| 9 | RIPK4 | 2.19532342 |
| 10 | MINK1 | 2.18424358 |
| 11 | MAP3K12 | 2.00414984 |
| 12 | STK39 | 1.96064946 |
| 13 | PRKD3 | 1.89862613 |
| 14 | TNIK | 1.85816612 |
| 15 | PRPF4B | 1.82870884 |
| 16 | NTRK2 | 1.79492279 |
| 17 | DAPK1 | 1.76597944 |
| 18 | KSR2 | 1.74862481 |
| 19 | PAK6 | 1.72159119 |
| 20 | MAP2K4 | 1.65679566 |
| 21 | CAMKK1 | 1.62761111 |
| 22 | PLK2 | 1.62199590 |
| 23 | MARK1 | 1.61934572 |
| 24 | STK24 | 1.59842394 |
| 25 | FES | 1.57529951 |
| 26 | NTRK1 | 1.54364726 |
| 27 | MET | 1.46316416 |
| 28 | CDK5 | 1.44378377 |
| 29 | KSR1 | 1.43557982 |
| 30 | CDK19 | 1.34077686 |
| 31 | AKT3 | 1.33137010 |
| 32 | MAP3K13 | 1.28268248 |
| 33 | PTK2B | 1.26282614 |
| 34 | STK38 | 1.25440274 |
| 35 | SGK223 | 1.24531168 |
| 36 | SGK494 | 1.24531168 |
| 37 | SGK2 | 1.23800778 |
| 38 | PRKCG | 1.18303272 |
| 39 | SIK2 | 1.16134260 |
| 40 | BMPR2 | 1.15457354 |
| 41 | ARAF | 1.12922695 |
| 42 | OXSR1 | 1.10233618 |
| 43 | GRK5 | 1.09508474 |
| 44 | CAMK2A | 1.06229093 |
| 45 | PKN1 | 1.05917911 |
| 46 | FGFR2 | 1.04121935 |
| 47 | MAPK13 | 1.02992788 |
| 48 | CCNB1 | 1.02550544 |
| 49 | SGK3 | 0.95164202 |
| 50 | PNCK | 0.94477891 |
| 51 | PINK1 | 0.93779395 |
| 52 | CAMKK2 | 0.91408224 |
| 53 | TYRO3 | 0.90817698 |
| 54 | TAOK1 | 0.90807700 |
| 55 | PRKCI | 0.89910569 |
| 56 | SIK3 | 0.89598982 |
| 57 | MAP3K2 | 0.88302183 |
| 58 | MAPKAPK5 | 0.86299543 |
| 59 | SGK1 | 0.86092750 |
| 60 | TNK2 | 0.85751864 |
| 61 | CAMK1 | 0.85647851 |
| 62 | CAMK1D | 0.84607977 |
| 63 | MAPK15 | 0.84368048 |
| 64 | PRKCH | 0.83695185 |
| 65 | CAMK2B | 0.83095711 |
| 66 | CSNK1G2 | 0.73829503 |
| 67 | CDK18 | 0.73220415 |
| 68 | LMTK2 | 0.72060219 |
| 69 | RAF1 | 0.72002105 |
| 70 | WNK4 | 0.71191488 |
| 71 | PRKG1 | 0.71153452 |
| 72 | STK38L | 0.70312700 |
| 73 | PRKCE | 0.69868690 |
| 74 | STK11 | 0.69574492 |
| 75 | CDK15 | 0.68376226 |
| 76 | TAOK3 | 0.68374068 |
| 77 | NEK6 | 0.67571279 |
| 78 | CSNK1G1 | 0.66828331 |
| 79 | CDK14 | 0.66664754 |
| 80 | MARK2 | 0.65645977 |
| 81 | PTK2 | 0.65337241 |
| 82 | AURKA | 0.65006538 |
| 83 | WNK1 | 0.64815088 |
| 84 | MOS | 0.64353305 |
| 85 | PHKG2 | 0.64169300 |
| 86 | PHKG1 | 0.64169300 |
| 87 | STK3 | 0.62840843 |
| 88 | MAPKAPK3 | 0.62020540 |
| 89 | LATS2 | 0.61143515 |
| 90 | GRK1 | 0.60387140 |
| 91 | RET | 0.60270783 |
| 92 | PDPK1 | 0.59595300 |
| 93 | MAP3K1 | 0.58123076 |
| 94 | PAK3 | 0.57001128 |
| 95 | CAMK1G | 0.56576182 |
| 96 | CDK11A | 0.56484310 |
| 97 | MAPK10 | 0.56480720 |
| 98 | BRSK1 | 0.56376482 |
| 99 | NLK | 0.56183643 |
| 100 | FER | 0.55425311 |
| 101 | BMPR1B | 0.55183516 |
| 102 | TTK | 0.54501933 |
| 103 | CSNK1D | 0.54403661 |
| 104 | PRKAA1 | 0.54375612 |
| 105 | PDK1 | 0.53152199 |
| 106 | UHMK1 | 0.52547438 |
| 107 | CAMK2D | 0.52212410 |
| 108 | DAPK3 | 0.51668876 |
| 109 | RPS6KA3 | 0.50133646 |
| 110 | FGR | 0.49988411 |
| 111 | CDK9 | 0.49829572 |
| 112 | PRKAA2 | 0.48907830 |
| 113 | MAPK7 | 0.48641081 |
| 114 | ROCK1 | 0.46898617 |
| 115 | CSNK1G3 | 0.46543470 |
| 116 | CSNK1E | 0.46092399 |
| 117 | DYRK1A | 0.45887748 |
| 118 | TRPM7 | 0.45316032 |
| 119 | MAPK12 | 0.45264624 |
| 120 | CAMK2G | 0.44399245 |
| 121 | NME1 | 0.44241361 |
| 122 | PRKCZ | 0.42791232 |
| 123 | MUSK | 0.42754309 |
| 124 | WNK3 | 0.42650169 |
| 125 | DMPK | 0.42099982 |
| 126 | MAP3K7 | 0.42029141 |
| 127 | FYN | 0.41601295 |
| 128 | ADRBK1 | 0.40073358 |
| 129 | CAMK4 | 0.39194713 |
| 130 | CDC42BPA | 0.39148117 |
| 131 | MAP2K1 | 0.38522627 |
| 132 | BCR | 0.36706554 |
| 133 | BRAF | 0.35864626 |
| 134 | GRK7 | 0.35808896 |
| 135 | PRKACA | 0.34545702 |
| 136 | PRKCA | 0.34439284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.70736896 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.26301309 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.84825009 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.79794057 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.74855638 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.71698634 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69987931 |
| 8 | * Morphine addiction_Homo sapiens_hsa05032 | 2.61511603 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.58407291 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.49954936 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.40450666 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.39207511 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.20266246 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06920593 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.98872561 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88745950 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87041918 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.84290291 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82894393 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73346908 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.70002289 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.69418972 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69038502 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67791430 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66464336 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66138487 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.57198376 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48669086 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35284244 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32802308 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32596996 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24384430 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.22110495 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20546793 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20490943 |
| 36 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16797948 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13123957 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12517984 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11984151 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10930480 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10579538 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.09762747 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08704328 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04898114 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.02052607 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.00578709 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97005045 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96640328 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 0.95863875 |
| 50 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95376989 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.94654799 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92812811 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90733671 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87921218 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87773607 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86935330 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84888451 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82720642 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80390501 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79150754 |
| 61 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78481402 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76636076 |
| 63 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71620093 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71591404 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69742528 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67901165 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67775221 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67354073 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66838538 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66804409 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65719231 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63940061 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63784008 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63395365 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60517198 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60134071 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58921472 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54406537 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54355505 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54079748 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53523384 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53439189 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49428734 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49363465 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.47606188 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47374523 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46993858 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46855280 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44102489 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43884219 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43826232 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42938224 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42748186 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42720963 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.40937631 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.40915742 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40758514 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40395362 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40079918 |
| 100 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39935495 |
| 101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38853638 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.38714373 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38276390 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37335144 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36679159 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36546073 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.36417233 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35450998 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35165220 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33719939 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33590333 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32810306 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.32085605 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31790710 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30887430 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30881829 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30803567 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30443847 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.29911778 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.29833172 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29088853 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28732402 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28389856 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27403439 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26361398 |

